Completed OBSERVATIONAL NCT00728364

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

A Case Finding Study for Anderson-Fabry Disease Among Patients With Chronic Kidney Disease Not on Renal Replacement Therapy

Sponsor: Genzyme, a Sanofi Company

Conditions Focus of Study: Prevalence of Fabry Disease in CKD Population

Updated 6 times since 2017 Last updated: Apr 10, 2012 Started: Oct 31, 2008 Primary completion: Aug 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Focus of Study: Prevalence of Fabry Disease in CKD Population and is currently completed. Genzyme, a Sanofi Company leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Genzyme, a Sanofi Company
Klinikum Wels-Grieskirchen

Data source: Klinikum Wels-Grieskirchen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wels, Austria